Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bluejay Diagnostics (BJDX) Net Income towards Common Stockholders (2022 - 2023)

Bluejay Diagnostics' Net Income towards Common Stockholders history spans 2 years, with the latest figure at -$2.4 million for Q4 2023.

  • For Q4 2023, Net Income towards Common Stockholders rose 2.73% year-over-year to -$2.4 million; the TTM value through Dec 2023 reached -$10.3 million, down 10.66%, while the annual FY2024 figure was -$20.9 million, 110.38% down from the prior year.
  • Net Income towards Common Stockholders for Q4 2023 was -$2.4 million at Bluejay Diagnostics, down from -$2.3 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$2.0 million in Q2 2022 and bottomed at -$2.9 million in Q2 2023.